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Abstract
Background: Intracranial Atherosclerotic Disease (ICAD) is the most frequent etiology of stroke with high
prevalence among Asians. Despite this, early determinants of ICAD have not been described from this region.
Methods: The study is an analytical prospective cross-sectional study of 200 adults from Radiology Departments of
two diagnostic centers in Karachi. Eligible participants confirmed the absence of stroke symptoms via the Questionnaire
for Verifying Stroke Free Status (QVSFS) and underwent an interview covering medical, socio demographic, lifestyle and
anthropometric evaluation using locally validated and standardized definitions. Magnetic Resonance Images (MRI) were
centrally reviewed to detect ICAD using the criterion used in the Warfarin–Aspirin Symptomatic Intracranial
Disease study. The risk factors associated with asymptomatic ICAD are reported along with prevalence ratios.
Results: Of the 200 participants, ICAD was found in 34.5% (n = 69) of the participants. Mean age was 37.1 (S.D 15.1)
years with 62% younger than 45 years. Self-reported hypertension was found in 26.5% subjects, diabetes in 9%,
dyslipidemia in 5% and depression in 60%. Smokeless tobacco (Adjusted PR 3.27 (1.07-6.05)), Western diet, high
socioeconomic status (Adjusted PR 2.26 (1.99-5.62)) and dyslipidemia (Adjusted PR 1.88 (1.25-2.21)) had significant
associations with ICAD after multivariable analysis. Age, gender, diabetes, hypertension, depression and physical
activity did not have a significant association.
Conclusion: ICAD was found on MRI in one in three asymptomatic Pakistanis and was associated with modifiable
risks. Initiatives targeting primary prevention may be able to decrease the burden of disease caused by stroke due
to ICAD.
Study Registration Number: NCT02072876 2/25/2014
Keywords: Intracranial atherosclerosis, Stroke, Asymptomatic, Developing countries, Prevention, Sociodemographic risk
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Background
Stroke is a leading cause of adult disability worldwide. It
is also thought to be the 2nd most common cause of
global mortality [1]. Among ischemic stroke sub-types,
intracranial atherosclerotic disease (ICAD) is regarded as
the most frequent etiology of stroke with high prevalence
among Asian, African and Hispanic individuals [2-8]. Early
data from Pakistan has also indicated a high prevalence of
ICAD [9].
Symptomatic atherosclerotic disease is preceded by
asymptomatic disease [10]. This provides us with an
opportunity for prevention [11]. For ICAD, prevention
is key since few relevant interventions exist once the dis-
ease is symptomatic, none of which are easily implementa-
ble in resource strapped regions [12]. However, in order to
formulate effective mechanisms of preventing stroke, it
is imperative to first identify the early determinants of
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ICAD. Although these determinants have been exten-
sively studied in the Western population, data is not al-
ways applicable to a population such as the one in
Pakistan due to different demographic and lifestyle
characteristics. Despite the high prevalence of ICAD,
data from Asian regions that bear large burdens of
ICAD is relatively scarce.
The objective of this study was to determine the clin-
ical, lifestyle, dietary and psycho-social determinants of
asymptomatic ICAD in Pakistanis who do not report
stroke symptoms on systematic review. These determi-
nants would help identify high risk behavior for stroke
in the Pakistani population.
Methods
Study design
This is a prospective cross-sectional study which was car-
ried out between March and June 2013 at the Radiology
Departments of Aga Khan University (AKU) and Dow
University of Health Sciences (DUHS).
Participating centers
Aga Khan University is a private not for profit academic
center with a fee for service system while Dow University
Radiology Center is public sector, government funded and
subsidized entity. Radiology departments in both centers
are equipped with 1.5 Tesla MRI scanners. The two cen-
ters are located in Karachi, Pakistan’s largest city with in-
habitants of all ethnicities [13]. They are the two largest
MRI scanning facilities in Karachi and perform greater
than a thousand neurologic scans per month.
Study population
We recruited adult Pakistani patients > 18 years of age
who presented to the participating centers for MRI of
the Brain for indications other than transient ischemic
attack (TIA) or stroke (e.g. headaches, epilepsy, rhino
sinusitis etc.). Subjects were required to have no history
of stroke or TIA, confirmed by a negative result on the
Questionnaire to Verify Stroke-free Status (QVSFS).
Data collection procedures/study flow
Non-probability purposive sampling was used to recruit
consecutive patients prospectively from the two sites.
Participants were screened for the absence of stroke via
QVSFS by trained medical officers after which an in-
formed consent was taken for enrollment into the study
[14,15]. An already tested Urdu version of QVSFS was
used [16-18]. Those who were QVSFS negative were sub-
ject to detailed interview and an additional 5 minute MRA
without contrast was done. Images were then collected on
Compact Disks (CD) by the designated research officers
which were then reviewed centrally by the vascular team
offline who were unaware of the patient’s clinical history.
The team evaluating the images had extensive experience
in systematically reviewing vasculature.
Data variables
A data collection form (DCF) was used that identified
and collected baseline demographic information. It also
consisted of an instrument that was used to record find-
ings from the MRI-MRA images. The instrument was
adapted from the work of Wardlaw [19,20] and it has
been used in a study previously [9].
Demographic and socio-economic
We collected information about age, sex, ethnicity, educa-
tion and marital status in addition to 5 questions regard-
ing income, occupation, number of household members
and household assets. For assessing household assets, the
Assets Questionnaire developed by the World Bank for
developing countries was used [21].
Principal component analysis (PCA) for socio-economic
status
To classify economic status, the following socioeconomic
variables were considered: individual’s profession, educa-
tion, household income, number of people sharing a room
in their house and household assets including property
(19 items). A principal component analysis (PCA) was ap-
plied to these socioeconomic indicator variables, which
showed relevant contributions (>10% and <70%) to the
combined socioeconomic status score factor [22]. The
factor of the PCA with the highest eigenvalue was used
as the variable to describe sufficiently the socioeco-
nomic status of a household. The respective factor
scores were categorized into tertiles and used in the re-
gression analysis. The lowest 33% of households accord-
ing to the economic status variable were classified as
belonging to low socioeconomic status, the highest 33%
as high socioeconomic status and the rest as middle
socio economic status [23].
Clinical
We inquired about clinical risk factors including diabetes,
hypertension, dyslipidemia, ischemic heart disease and
atrial fibrillation. Hypertension was defined as those with
elevated systolic blood pressure >140 mmHg or diastolic
blood pressure >90 mmHg [24], or those with a clear
hypertension medical record, or record of antihypertensive
drugs usage. Subjects with diabetes mellitus were those
with documented diabetes in their medical records, those
having a random glucose level of >11.1 mmol/L (200 mg/dl)
or those on anti-diabetics [25]. Dyslipidemia was de-
fined as total cholesterol >200 mg/dl or LDL (Low
density lipo-protein) >160 mg/dl or those taking lipid-
lowering drugs [26]. IHD (Ischemic heart disease) was
defined as a known history of myocardial infarction or
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angina. Anthropometric indices were done for the meas-
urement of general and central obesity. For categorizing
BMI (Body mass Index) World Health Organization’s
(WHO) recommendations for Asian population were used
[27]. SRQ was used for assessing depression, its validity
has been tested in Pakistani population and found to have
good psychometric properties with sensitivity of 78% and
specificity of 81% [17].
Assessment of dietary pattern
For the purpose of this analysis we divided dietary patterns
as “prudent” and “western” diet based on the nature of the
food stuff being consumed. These are descriptive labels
for the purposes of this study only and do not generalize
or imply dietary culture per se. Data was collected on a
Food Frequency Questionnaire (FFQ) (Additional file 1).
Prudent diet pattern for this study represented high in-
takes of vegetables, fruit, legumes, fish, poultry, and whole
grains, whereas Western diet for the purpose of analysis
reflects high intakes of red meat, processed meat, refined
grains, french fries, and sweets/desserts.
To identify dietary patterns, the items of the FFQs
were first grouped into 29 food groups [28,29]. The clas-
sification of food groups was based on similarities in nu-
trient profile and culinary preference. Factor analysis
(principal component analysis) was then applied with
the orthogonal rotation procedure varimax to the prede-
fined food groups.
We determined the dietary patterns to retain based on
the Scree test [30] (a graphical presentation of eigenvalues,
with eigenvalues >1 explaining more variance than an in-
dividual food group) and the interpretability of factors.
The Scree test allowed us to identify 2 major patterns with
the largest eigenvalues (≥3.09). These patterns were la-
beled the “prudent” and the “Western” patterns as above.
The scores of each of these patterns were then divided
into quintiles with higher quintile representing higher ad-
herence to that dietary pattern.
Assessment of physical activity
MET minutes/week score for walking, moderate and vig-
orous activity were calculated from IPAQ short by multi-
plying the total minutes per week of that activity by its
designated MET score [31]. Total MET minutes per week
were calculated by summing up the walking, moderate
and vigorous MET minutes per week. This was then used
to categorize physical activity into low, moderate and high
according to the following criteria: <600 MET-minutes/
week as low physical activity, between 600 MET-minutes/
week and 3000 MET-minutes/week as moderate physical
activity and >3000 MET-minutes/week as high physical
activity (Additional file 2).
Radiologic assessment
Intracranial Stenosis on MRA was defined as any artery
(bilateral anterior cerebral arteries (A1 & A2), bilateral
middle cerebral arteries (M1 & M2), bilateral posterior
cerebral arteries, bilateral vertebral arteries, bilateral in-
ternal carotid artery- petrous bilateral internal carotid
artery- cavernous, bilateral internal carotid artery- supra-
clinoid and basilar artery) showing abnormality when
imaged by time of flight MRA method. Any degree of
stenosis was classified as diseased. This ranged from ath-
erosclerotic irregularity to complete occlusion. We used
this stratification since data suggests that even minor de-
grees of ICAD can result in fatal strokes, mediated by
platelet destabilization, plaque rupture etc. in addition to
simple progressive atherosclerotic stenosis. Since which
minimal stenosis can be potentially associated with clin-
ically significant outcomes [32] we considered all bio-
logically involved vessels.
An internationally standardized equation was used to
calculate the degree of stenosis. This method has also
been used successfully in a Pakistani study [9] to meas-
ure symptomatic intracranial stenosis.
Percent stenosis ¼ 1− D stenosis=D normalð Þ  100½ 
where D Stenosis is the diameter of the artery at the
site of the most severe stenosis, and D normal is the
diameter of the proximal normal artery [19].
We stratified the degree of stenosis to better understand
the burden and distribution of ICAD in our population;
we were not able to stratify our analysis according the de-
gree of stenosis due to a small number of diseased arteries
expected from our study.
Statistical analysis
Sample size estimation
A minimum sample size of 200 participants was required
in order to achieve 80% power for detecting a minimum
difference of 20% in the prevalence of radiological findings
between asymptomatic ICAD positive and ICAD negative
persons. This was calculated assuming a 1:3 ratio in pa-
tients with ICAD versus no ICAD based on previous stud-
ies from Asia [33-36] and at a level of significance of 5%.
Statistical analysis
Mean and standard deviations (SD) were calculated for
continuous variables like age and BMI and proportions
for categorical variables like education, ICAD, clinical
and lifestyle factors. The independent contribution of
any risk factor to ICAD was examined in the univariate
and subsequent multivariable Cox proportional hazards
algorithm and prevalence ratios and 95% confidence in-
tervals were reported.
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Ethical approval and human subjects protection
All participants provided written informed consent. Ethical
approval was taken from AKU Ethical Review Committee
and the Institutional review board of DUHS. (ERC number
2327 CHS ERC 12 and IRB 360/DUHS 2012). All scans
were reviewed within 24 hours by the radiology faculty and
there was provision in the study to report any critical, life
threatening incidental findings like aneurysms first to the
referring physician and in his absence or inability to con-
tact, the report was communicated to the patient with an
urgent referral. All data was numerically coded so as not
to reveal the identity of the participants. All electronic
transfer within centers was done through decoded CDs
that were centralized to a single password protected work-
station for analysis.
Results
Out of 283 subjects approached at the two study sites
(197 at DUHS, 86 at AKUH), 200 were recruited for this
study (156 at DUHS and 44 at AKUH). Of those ex-
cluded from the study most patients had stroke as an in-
dication for MRI (37.3%) or did not consent for the
study (33.7%) (Figure 1). The most common indication
for the MRI was headache (52%). Out of the 200 who
participated in the study, 69 (34.5%) were found to have
clinically significant ICAD.
Demographics
Sociodemographic details of study participants are pre-
sented in Table 1. Mean age of the participants was
37.1 years (S.D 15.1) years with nearly 62% of the partic-
ipants being younger than 40 years. There was an equal
Figure 1 Study flow diagram.
Table 1 Socioeconomic and demographic profile of study
participants
SOCIO-ECONOMIC
FACTORS
Frequency in
patients with ICAD
69 (34.5%) n (%)
Frequency in
patients with no ICAD
131 (65.5%) n (%)
Age (Years)
Mean (SD) 38.6 (15.1) 36.31 (15)
Gender
Males 36(52.2%) 65(49.6%)
Females 33 (47.8%) 66 (50.4%)
Ethnicity
Urdu speaking 28 (40.7%) 46 (35%)
Pathan 17 (24.6%) 26 (19.8%)
Sindhi 6 (8.7%) 23 (17.6%)
Balochi 4 (5.8%) 11 (8.4%)
Punjabi 7 (10.1%) 8 (6.1%)
Others 7 (10.1%) 17 (13%)
Education
Illiterate 16 (23.2%) 30(22.9%)
Madressa 6 (8.7%) 13 (10%)
Primary 9 (13%) 11 (8.4%)
Secondary 12 (17.4%) 45 (34.4%)
Graduate and above 26(37.7%) 32 (24.4%)
Occupation
Employed 26 (37.7%) 30 (23%)
Unemployed 3 (4.3%) 12 (9.2%)
Retired 2 (2.9%) 4 (3.1%)
Housewife 23 (33.3%) 60 (45.8%)
Laborer 5 (7.2%) 9 (6.9%)
Business and others 10 (14.5%) 16 (12.2%)
Socio-economic status
Low 24 (34.8%) 42 (32.1%)
Middle 16 (23.2%) 51 (38.9%)
High 29 (42%) 38 (29%)
Indications for MRI
Headache 34 (49.3%) 71 (54.2%)
Dizziness 0 8 (6.1%)
Headache & dizziness 1 (1.4%) 9 (7%)
Tremors 1 (1.4%) 4 (3.1%)
Seizures 3 (4.3%) 4 (3.1%)
Others 32 (46.5%) 35 (26.5%)
City of residence
Karachi 25 (36.2%) 51 (39%)
Quetta 9 (13%) 20 (15.2%)
Hyderabad 10 (14.5%) 15 (11.4%)
Gilgit 8(11.5%) 9 (6.8%)
Other cities 17 (24.6%) 36 (27.4%)
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proportion of males and females. The largest ethnic group
was the Urdu speaking community (37%, n = 74) followed
the Punjabi community. There were no significant differ-
ences between the age, gender or ethnic distribution be-
tween patients with and without ICAD. Although the
proportion of low socioeconomic status was roughly equal
in the two groups (34.8%, n = 24 and 32.1%, n = 42), the
proportion of high socioeconomic status of the subjects
with ICAD was higher in patients with ICAD (42%,
n = 29) compared to those without ICAD (29%, n = 38).
Most participants understandably belonged to Karachi
with relatively small proportions of participants from
other cities. Subjects with ICAD tended to be more edu-
cated than the ones without ICAD (37.7% with ICAD
were graduates compared to 24.4% without ICAD).
Risk factors
Table 2 shows the risk factors of stroke in study partici-
pants with and without ICAD. Among the clinical deter-
minants of ICAD, hypertension (26.5% of subjects, n = 53)
was most commonly found followed by diabetes (9%,
n = 18) There were no major differences in the propor-
tions of subjects with and without ICAD in any of the
diseases mentioned above. Dyslipidemia however was
significantly associated with ICAD (p value: 0.04).CVD
and Atrial fibrillation were present in very low propor-
tions in both groups and did not show any significant
associations with ICAD.
Similarly, the physical activity level in the two groups
was almost identical with over 80% of participants in
both groups having low physical activity levels. Mean
BMI was 25 kg/m2 (S.D 6.4 kg/m2) and mean waist cir-
cumference was 77 cm (S.D 14.88 cm). Using the cutoffs
recommended for South Asians [25], 42% (n = 84) of the
participants were above normal BMI range (obese + over-
weight). There were however no significant differences be-
tween the two groups.
The diet of the study participants varied between the
groups with and without ICAD. Patients with ICAD
were more likely to be on a higher quintile of Western
and prudent diet as compared to those without ICAD.
Among the lifestyle determinants of ICAD, 12% of the
study participants had a history of smokeless tobacco
use (mostly niswar) with only 8% being current smokers.
Understandably, the subjects with ICAD had a signifi-
cantly higher proportion of using smokeless tobacco
compared to those without ICAD (p value:0 02).
The frequency of depression (SRQ cut-off > 8) in the
current sample of participants was 60%, even though a
high cut-off point was used rather than the mean score.
The proportion of subjects with (56.5%, n = 39) and
without ICAD (61.8%, n = 81) however had no signifi-
cant differences (p value: 0.17).
When multivariable cox regression analysis was applied,
smokeless tobacco (PR 3.27; 95% CI 1.07-6.05) and higher
quintiles of western diet (PR 3.04; 95% CI 1.15-7.99) were
found to be significantly associated with ICAD. All bio-
logically plausible interactions between clinical and life-
style factors were checked but no significant interactions
were found.
After further adjustment for the clustering effect (study
centers) younger age (<45 years) was found to be signifi-
cantly associated with ICAD (PR 1.94; 95% CI 1.85-1.97).
Among the vascular risk factors presence of cardiovascular
disease (PR 1.15; 95% CI (1.06-1.36) came out to be sig-
nificantly associated with asymptomatic disease, besides
lifestyle factors of increased consumption of western diet
and smokeless tobacco use (Table 3).
Discussion
To the best of our knowledge this is the first study con-
ducted in South Asia that identifies early determinants
of ICAD by looking at asymptomatic subjects. The
major finding of this study is that modifiable risk factors
such as dyslipidemia, tobacco chewing and overconsump-
tion of a Western diet, which are all increasing in preva-
lence in our population are associated with asymptomatic
ICAD. The most commonly affected arteries were the
Posterior Cerebral arteries followed by Vertebral and
Middle Cerebral arteries. Of all affected arteries, about
20% showed complete occlusion in clinically silent
areas. Furthermore, it also showed a high prevalence of
depression and sedentary lifestyle in the study popula-
tion, both of which are stroke risk factors. The findings
provide us with direction for implementation of initia-
tives that target primary prevention.
The proportion of patients with ICAD (34.5%) was sig-
nificantly higher than that reported in previous studies
from other parts of the world [37-39] that have reported
figures between 4% and 29%. Although a figure as high
as this cannot be ignored, the recruitment bias intro-
duced choosing participants with a preexisting indication
for an MRI would suggest that this figure might be
falsely elevated.
The study had a young (mean age 37.1 yrs) population
in general but importantly there was no significant dif-
ference in the ages of the subjects with and without
ICAD. The finding is not consistent with previous simi-
lar studies [10,35,40,41] from other parts of the world
which report an association between increasing age and
ICAD. However, this observation can still be explained if
the findings of a previous study on the Pakistani popula-
tion [16] is taken into consideration. Atherosclerotic dis-
ease takes years to develop and the study mentioned
above showed the mean age of patients of symptomatic
ICAD to be 50.1 years. This essentially suggests that a
significant number of young apparently healthy Pakistanis
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have asymptomatic ICAD which can eventually progress
to symptomatic ICAD. Further, ICAD is not entirely ex-
plained by traditional risks like hypertension, diabetes, and
dyslipidemia, and emerging factors like plasma homocyst-
eine, angiotensin-converting enzyme polymorphism, and
inflammatory cytokines may affect its development. These
Table 2 Risk factors for asymptomatic ICAD
RISK FACTORS Frequency of patients
with ICAD (%)
Frequency of patients
without ICAD (%)
Unadjusted
PR (CIs)
Adjusted
PR (CIs)
P-value
(<0.05 sig.)
Socioeconomic status
Low 24 (34.8%) 42 (32.1%) 1 1 0.05
Middle 16 (23.2%) 51 (38.9%) 0.66 (0.35-1.24) 0.67 (0.33-1.35) .07
High 29 (42%) 38 (29%) 1.21 (0.70-2.08) 2.26 (1.99-5.62) 0.03
Clinical risk factors
Diabetes 4 (5.8%) 14 (10.7%) 0.62 (0.23-1.70) 0.58 (0.2-1.67) 0.27
Hypertension 17 (24.6%) 36 (27.5%) 0.97 (0.84-1.12) 0.98 (0.89-1.08) 0.76
Dyslipidemia 7 (10.3%) 3 (2.2%) 1.16 (0.37-3.70) 1.88 (1.25-2.21) 0.04
CVD 2 (2.9%) 1 (.8%) 0.51 (0.13-2.09) 0.30 (0.06-1.43) 0.13
A.Fib 1 (1.4%) 2 (1.5%) 1.04 (0.15-7.49) 1.44 (0.17-3.39) 0.73
Lifestyle factors
Current smoking 5 (7.2%) 11 (8.4%) 1.12 (0.45-2.78) 1.73 (0.24-2.27) 0.59
Past smoking 3 (4.3%) 10 (7.6%) 1.54 (0.48-4.89) 2.19 (0.51-3.81) 0.30
Smokeless tobacco 19 (27.9%) 5 (3.8%) 1.76 (0.71-4.36) 3.27 (1.07-6.05) 0.02
BMI categories
Normal 11 (16%) 15 (11.5%) 1 1 0.67
Underweight 20 (29%) 39 (29.8%) 1.30 (0.62-2.71) 1.73 (0.77-3.88) 0.21
Pre-over weight 10 (14.5%) 20 (15.3%) 0.98 (0.46-2.10) 0.92 (0.45-1.84) 0.64
Over-weight 14 (20.3%) 34 (26%) 0.86 (0.44-1.70) 1.18 (0.54-2.60) 0.75
Obese 13 (18.8%) 23 (17.6%) 1.07 (0.53-2.14) 1.13 (0.53-2.38) 0.70
Central obesity
Waist 19 (27.5%) 30 (23%) 1.20 (0.70-2.03) 1.14 (0.64-2.03) 0.65
Circumference > 80 cms
Physical activity
Low 56 (81.2%) 106 (81%) 1 1 0.84
Moderate 3 (4.3%) 6 (4.6%) 0.96 (0.30-3.06) 1.04 (0.32-3.41) 0.09
High 10 (14.5%) 19 (14.5%) 0.99 (0.51-1.94) 1.25 (0.59-2.65) 0.54
Western diet
Quintile 1 6 (8.7%) 31 (23.7%) 1 1 0.15
Quintile 2 16 (23.2%) 23 (17.6%) 2.46 (0.96-6.29) 2.24 (0.79-6.39) 0.10
Quintile 3 18 (26%) 21 (16%) 2.77 (1.10-6.98) 2.58 (0.95-2.61) 0.14
Quintile 4 13 (18.8%) 26 (19.8%) 2.01 (0.76-5.26) 2.86 (1.11-7.41) 0.02
Quintile 5 13 (18.8%) 25 (19%) 2.05 (0.78-5.40) 3.04 (1.15-7.99) 0.03
Prudent diet
Quintile 1 11 (16%) 26 (19.8%) 1 1 0.47
Quintile 2 13 (21.5%) 28 (21.4%) 0.95 (0.41-2.19) 1.02 (0.42-2.4) 0.95
Quintile 3 7 (12%) 30 (22.9%) 0.78 (0.32-1.87) 0.76 (0.31-1.92) 0.57
Quintile 4 9 (13%) 9 (7%) 1.68 (0.69-4.06) 1.39 (0.55-3.49) 0.48
Quintile 5 25 (36.2%) 33 (25.2%) 1.48 (0.73-2.99) 1.5 (0.71-3.18) 0.29
Depression 39 (56.5%) 81 (61.8%) 0 .85 (0.53-1.37) 0.91 (0.54-1.53) 0.17
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biochemical investigations were beyond the capacity of
this study [42-44].
Stroke is common in males and this observation is
more pronounced in ischemic strokes [45-47]. It also oc-
curs at a younger age in males compared to females
[48,49]. With a young study population, as in this study,
the same finding would be expected. This study however
does not report a gender predilection. This finding, al-
though not common, has been shown in previous studies
[35,40] from other Asian countries. Interestingly a study
[50] by Jafar et al. on 3143 Pakistani adults did report that
women in Pakistan were at higher risk than men for cor-
onary artery disease due to higher number of risk factors
(diabetes, hypertension, obesity, dyslipidemia). Since the
same risk factors as applicable to ICAD, we theorize
that the equal risk of vascular disease observed in the
cardiac population also applies to the cerebrovascular
risk patients.
When looking at the lifestyle factors, our study find-
ings suggest that a high socioeconomic status is signifi-
cantly associated with stroke. Review studies [51,52] that
have specifically addressed the association between so-
cioeconomic status and stroke have documented that it
is in fact low socioeconomic status that is associated
with higher incidence and severity of stroke. We suggest
that lifestyle choices associated with the higher socioeco-
nomic status such as adoption of Western diet have con-
tributed to a higher incidence of stroke in our transitional
population [53]. What adds weight to this argument is that
the western diet has also been shown to be significantly
associated with ICAD in our study (Adjusted PR 2.86
(1.11-7.41) for quintile 4 and Adjusted PR 3.04 (1.15-7.99)
for quintile 5). There is documented evidence of the pro-
inflammatory effects of Western diet [54-57] especially
when taken in large quantities. The finding emphasizes
the need to address the adaptation of Western diet before
it adds to the burden of non communicable diseases in
Pakistan which is now becoming endemic.
The use of smokeless tobacco is Pakistan is rampant with
an estimated prevalence between 16% and 26% [58-61].
Overall prevalence of smokeless tobacco use was 12% in
our study which was higher in participants with ICAD
compared to those without. The association was of
ICAD was found to be significant after multivariate ana-
lysis (Adjusted PR 3.27) reiterating the increased risk of
stroke with use of smokeless tobacco which has docu-
mented before [62].
The causal relationship of diseases such as dyslipid-
emia, hypertension and diabetes with ICAD is well stud-
ied and hence we did not look to screen patients for
these diseases. The presence or absence of these diseases
was mostly based on history and a single blood pressure
reading and random blood sugar test. The ascertainment
bias resulting from this methodology could have contrib-
uted to the finding that apart from dyslipidemia, no other
diseases such as hypertension and diabetes showed an as-
sociation with ICAD. At the same time what also needs to
be considered is the fact that a lot of these subjects were
young and they might develop these diseases in the future
and ICAD has simply manifested earlier due to lifestyle
choices.
The association of depression with intracranial disease
has been studied before and it has been suggested that
small brain infarctions can cause depression [63,64].
Through our study we attempted to establish an associ-
ation, if any, of ICAD and depression. Recent data
[65-68] reports the prevalence of depression among the
residents of Karachi between 16% and 70%. Taking this
into consideration we used a high cut off score for the
SRQ (>8) to increase the specificity (Positive predictive
value is 98% at this SRQ score). The study however still
showed depression in more than half the subjects. With
such a high figure, distributed equally across the study
population, it is very difficult to establish any associ-
ation. Similarly, more than 80% of the participants had a
low physical activity level. With a prevalence as high as
this, it is not possible to establish an association.
We feel that our preliminary observations have impact
and relevance in a global context.
In a resource strapped country like Pakistan, we feel
the key to tackling a health issue like ICAD lies in pri-
mary prevention. Evidence currently available for the
Table 3 Multivariable model adjusted for clustering effect
(Study Centers)
Factor Unadjusted PR Adjusted PR P-value
Sociodemographic factors
Age < 45 yrs 1.16 (1.13-1.19) 1.94 (1.85-1.97) 0.03
Socioeconomic Status
Low 1 1 0.01
Middle 0.65 (0.34-1.24) 0.55 (0.51-0.59) 0.36
High 1.16 (1.08-1.41) 1.39 (1.08-1.83) 0.02
Vascular related
HTN 1.96 (1.83-2.13) -
CVD 1.51 (1.39-1.64) 1.15 (1.06-1.36) 0.03
Lifestyle related
Smokeless tobacco 1.73 (1.57-1.89) 1.77 (1.54-2.03) 0.04
Waist 1.22 (1.20-2.24) -
Western diet
Quintile 1 1 1 0.01
Quintile 2 2.4 (2.2-2.6) 2.85 (2.06-3.95) 0.03
Quintile 3 2.46 (2.44-2.48) 2.87 (1.79-4.6) 0.03
Quintile 4 2.95 (1.78-4.87) 3.54 (2.68-4.68) 0.02
Quintile 5 3.32 (2.8-3.9) 3.9 (2.87-5.3) 0.01
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therapies of ICAD [69-73] from developed countries
shows that these interventions are not only expensive
but often ineffective, and difficult to execute at best in
low middle income settings.
Our suggestion to focus on controlling non commu-
nicable risk factors to reduce the burden of disease is
not novel to low middle income regions. Our review of
these initiatives reveals interventional projects in similar
settings that addressed non communicable diseases and
showed promising results [74-79]. What is lacking are
holistic, stroke based or multiple risk initiatives.
Our study has several strengths. Our participants were
chosen from the general population rather than from a
high risk population. A detailed review of asymptomatic
status was done by using a validated questionnaire (QVSFS)
which to rule out clinical stroke with 95% sensitivity
and specificity. This tool has also been used in Pakistan
previously [16]. Rigorous training was given to all data
collectors so that a standard protocol was implemented
at both centers. A round the clock back up was available
by stroke neurologists further adding clarity to the par-
ticipant stroke free status. Both study centers were also
equipped with a similar MRI scanner (1.5 Tesla) using
standardized protocol thus reducing detection bias.
Centralized coding system for MRA and specialized
software was used for storing and image viewing. This
study also assessed a number of novel risk factors for
ICAD like socio-demographic factors, physical activity,
diet and depression that have not always been explored
using previously validated tools.
Our study has certain limitations. Since this is a cross
sectional study, temporality cannot be assessed and no
conclusions can be deduced regarding causality.There is
a recruitment bias when we selected our participants
from those who had a preexisting indication for an MRI.
Secondly, the medical risks reported here (Hypertension
and Diabetes) are self-reported, so that there may have
been under-reporting and recall bias. This study also has
a diagnostic limitation since we did not use a 4 vessel
angiogram for diagnosing ICAD. This is because 4 Vessel
angiography has a 1.5 - 3% risk of stroke [80]. Using this
on otherwise healthy stroke free patients would be uneth-
ical. We used the MRI instead, which is a noninvasive tool
with a high negative predictive value [81]. Using biochem-
ical investigations such as homocysteine levels would have
been relevant to identifying determinants of ICAD; how-
ever this was beyond the scope of this study, as was the
opportunity to do risk loading stratified analysis based
on degree of stenosis or the presence or absence of
stroke and stroke brain volumes, both of which are ave-
nues for further investigations. Furthermore, our data
essentially applies to urban transitional Pakistan since
rural based populations are not well represented in this
study.
Conclusion
In conclusion, we have demonstrated that the distribu-
tion of ICAD in young Pakistanis is frequent and equally
distributed across gender and is associated with modifi-
able risks. Future studies should focus on longitudinal
assessment of ICAD, and holistic risk reduction based
interventions on younger populations.
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